Umbilical cord blood as a promising source of NK cells for immunotherapy

Autor: R. A. Velichinskii, J. D. Vavilova, A. A. Boyko, O. A. Shustova, A. I. Palamarchuk, G. M. Yusubalieva, O. N. Kucherova, M. A. Streltsova, E. I. Kovalenko

Publikováno v: Медицинская иммунология, Vol 25, Iss 5, Pp 1259-1264 (2023)

Currently, a large number of studies on genetic modification of cord blood NK cells (UCB-NK) are carried out at both clinical and preclinical levels. Immunotherapy based on UCB-NK cells has great potential for antitumor therapy. However, despite havi

Externí odkaz: https://doaj.org/article/b387584561524984832f54f529f7036a

The Antigen-Specific Response of NK Cells to SARS-CoV-2 Correlates With KIR2DS4 Expression.

Autor: Ustiuzhanina MO; Department of Genomics of Adaptive Immunity, Department of immunology, Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.; Institute of Translational Medicine, Pirogov Russian National Research Medical University, Moscow, Russia., Boyko AA; Department of Genomics of Adaptive Immunity, Department of immunology, Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia., Vavilova JD; Department of Genomics of Adaptive Immunity, Department of immunology, Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia., Siniavin AE; Department of Genomics of Adaptive Immunity, Department of immunology, Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.; Arbovirus and Experimental Production Department, Federal State Budget Institution 'National Research Centre for Epidemiology and Microbiology Named After Honorary Academician N. F. Gamaleya' of the Ministry of Health of the Russian Federation, Moscow, Russia., Streltsova MA; Department of Genomics of Adaptive Immunity, Department of immunology, Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia., Astrakhantseva IV; Division of Immunobiology and Biomedicine, Center of Genetics and Life Sciences, Sirius University of Science and Technology, Federal Territory Sirius, Russia., Drutskaya MS; Division of Immunobiology and Biomedicine, Center of Genetics and Life Sciences, Sirius University of Science and Technology, Federal Territory Sirius, Russia.; Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia., Chudakov DM; Department of Genomics of Adaptive Immunity, Department of immunology, Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.; Institute of Translational Medicine, Pirogov Russian National Research Medical University, Moscow, Russia.; Central European Institute of Technology, Masaryk University, Brno, Czech Republic.; Department Bioinformatics, Abu Dhabi Stem Cell Center, Al Muntazah, Abu Dhabi, United Arab Emirates., Kovalenko EI; Department of Genomics of Adaptive Immunity, Department of immunology, Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.

Publikováno v: Journal of medical virology [J Med Virol] 2024 Nov; Vol. 96 (11), pp. e70057.

Study Findings from Russian Academy of Sciences Update Knowledge in Immunotherapy (Umbilical cord blood as a promising source of NK cells for immunotherapy).

Publikováno v: Cancer Gene Therapy Week; 7/3/2023, p47-47, 1p